Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancer.
Baykara M, Coskun U, Berk V, Ozkan M, Kaplan MA, Benekli M, Karaca H, Inanc M, Isikdogan A, Sevinc A, Elkiran ET, Demirci U, Buyukberber S.
Baykara M, et al. Among authors: karaca h.
Asian Pac J Cancer Prev. 2012;13(10):5119-24. doi: 10.7314/apjcp.2012.13.10.5119.
Asian Pac J Cancer Prev. 2012.
PMID: 23244121
Free article.